Celcuity Inc

CELCNASDAQ · Services-Medical Laboratories

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

48.9M

on 2026-06-30, from 30.8M on 2024-03-31 10-Q ↗

Newest

No limit

S-3ASR of 2026-01-09. An automatic shelf: the form sets no dollar limit. 2 prospectus supplements filed under it since. S-3ASR ↗

$400.0M

Jefferies, agreement of 2026-01-09. No at-the-market sales statement read from a 10-Q or 10-K. S-3ASR ↗

Warrants

6.42B

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

15.7 quarters

$754.0M on 2026-06-30 ÷ $47.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 18 of its filings are not read yet.

Also on file: $50.0M convertible notes, 2026-06-03 8-K ↗ · $500 convertible notes, 2026-06-05 424B5 ↗